Is the treatment with biological or non-biological DMARDS a modifier of periodontal condition in patients with rheumatoid arthritis?

Romero-Sánchez, ConsueloRodrígue, C.Santos-Moreno, P.Mesa, A.Lafaurie, Gloria InesGiraldo-Q, S.De-Avila, J.Castillo, DM.Duran, M.Chalem Ch, P.Bello Gualtero, JM.Valle-Oñate, R.2020-08-042020-08-041875-6360https://hdl.handle.net/20.500.12495/3658application/pdfengIs the treatment with biological or non-biological DMARDS a modifier of periodontal condition in patients with rheumatoid arthritis?Artículo de revistaPeriodontal diseaseAntagonist tumor necrosis factor alpha (anti-TNF- alpha)Diseasemodifying anti-rheumatic drug (DMARDs)Rheumatoid arthritishttps://doi.org/10.2174/1573397113666170407161520instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coIs the treatment with biological or non-biological DMARDS a modifier of periodontal condition in patients with rheumatoid arthritis?Acceso abiertohttps://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2017